Dose-dependent Localisation and Potential for Therapy of F(ab')2 Fragments Against CEA Studied in a Human Tumour Xenograft Model
Overview
Affiliations
El-Sayed A, Mohamed N, Yassin M, Amer M, El-Sharkawy R, El-Sayed N Heliyon. 2022; 8(9):e10660.
PMID: 36164544 PMC: 9508425. DOI: 10.1016/j.heliyon.2022.e10660.
Antibody-directed enzyme prodrug therapy.
Bagshawe K Clin Pharmacokinet. 1994; 27(5):368-76.
PMID: 7851054 DOI: 10.2165/00003088-199427050-00004.
Rogers G, Pedley R, Boden J, Harwood P, Bagshawe K Cancer Immunol Immunother. 1986; 23(2):107-12.
PMID: 3779712 PMC: 11038251. DOI: 10.1007/BF00199815.
Theoretical considerations for improving tumour targeting.
Thomas G, Chappell M, Dykes P, Ramsden D, Godfrey K, Ellis J Br J Cancer Suppl. 1990; 10:70-3.
PMID: 2383483 PMC: 2149514.
Sharma S, Bagshawe K, Burke P, BODEN R, Rogers G Br J Cancer. 1990; 61(5):659-62.
PMID: 2337503 PMC: 1971605. DOI: 10.1038/bjc.1990.149.